Gomika Udugamasooriya to Cell Line, Tumor
This is a "connection" page, showing publications Gomika Udugamasooriya has written about Cell Line, Tumor.
Connection Strength
0.732
-
A novel peptidomimetic therapeutic for selective suppression of lung cancer stem cells over non-stem cancer cells. Bioorg Chem. 2021 11; 116:105340.
Score: 0.178
-
Design of a dual ERK5 kinase activation and autophosphorylation inhibitor to block cancer stem cell activity. Bioorg Med Chem Lett. 2020 Dec 01; 30(23):127552.
Score: 0.166
-
A unique mid-sequence linker used to multimerize the lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1. Eur J Med Chem. 2017 Sep 08; 137:1-10.
Score: 0.132
-
A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1. Biochem Biophys Res Commun. 2017 Apr 29; 486(2):545-550.
Score: 0.131
-
Identification of the minimum pharmacophore of lipid-phosphatidylserine (PS) binding peptide-peptoid hybrid PPS1D1. Bioorg Med Chem. 2016 Sep 15; 24(18):4470-4477.
Score: 0.125